Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,538.70
(
-1.03%
)
US TECH 100
23,411.12
(
-1.31%
)
Dow Jones
45,781.18
(
-0.52%
)
Brent Oil
107.25
(
2.70%
)
Bitcoin
69,589.00
(
-0.44%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 167702

Monday, 10/14/2013 5:33:32 PM

Monday, October 14, 2013 5:33:32 PM

Post# of 257262
PTLA issues fluff PR with interim “n=6” data on PRT4445 with Eliquis:

http://finance.yahoo.com/news/portola-pharmaceuticals-announces-first-phase-210500300.html

Presumably, this PR is to pump the stock for the $100M offering in progress (of which a portion of the shares sold will come from insiders rather than the company itself).

I stand by the generally bearish comments in #msg-92793714.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today